Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Post-Mkt 12-18 17:10:31 EST

5.75

-0.11

-1.88%

盘后5.84

+0.09+1.56%

16:55 EST

High6.04	Low5.70	Vol73.43K
Open5.87	D1 Closing5.86	Amplitude5.80%
Mkt Cap47.74M	Tradable Cap31.81M	Total Shares8.30M
T/O428.39K	T/O Rate1.33%	Tradable Shares5.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":5.75,"timestamp":1766091600000,"preClose":5.86,"halted":0,"volume":73427,"hourTrading":{"tag":"盘后","latestPrice":5.8395,"preClose":5.75,"latestTime":"16:55 EST","volume":15,"amount":87.1415025,"timestamp":1766094943127},"delay":0,"floatShares":5531900,"shares":8302700,"eps":-1.167371,"marketStatus":"Post-Mkt","change":-0.11,"latestTime":"12-18 17:10:31 EST","open":5.87,"high":6.0399,"low":5.7,"amount":428392.6275539,"amplitude":0.058003,"askPrice":5.84,"askSize":510,"bidPrice":5.72,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.167371,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766106000000},"marketStatusCode":4,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":5.86,"preHourTrading":{"tag":"盘前","latestPrice":5.8277,"preClose":5.86,"latestTime":"08:32 EST","volume":301,"amount":1754.124456,"timestamp":1766064764319},"postHourTrading":{"tag":"盘后","latestPrice":5.8395,"preClose":5.75,"latestTime":"16:55 EST","volume":15,"amount":87.1415025,"timestamp":1766094943127},"volumeRatio":1.168052,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX/tweets","defaultTab":"tweets","newsList":[{"id":"2591628605","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2591628605","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591628605?lang=en_us&edition=fundamental","pubTime":"2025-12-16 00:08","pubTimestamp":1765814936,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 0.57% to 1,657.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by brewing company Anheuser-Busch InBev  and lender Banco Santander , which advanced 2.3% and 1.5%, respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria  and biopharmaceutical company DBV Technologies , which were up 0.7% and 0.5%, respectively.The decliners from continental Europe were led by biopharmaceutical company argenx  and biotech firm Evaxion , which fell 4.9% and 4.4%, respectively. They were followed by internet advertising firm Criteo  and Sequans Communications , which were down 3.1% and 2.2%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and biotech firm Trinity Biotech , which rose 14% and 3.7%, respectively. They were followed by lender Barclays  and insurance compa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DBVT","BBVA","EVAX","SAN.AU","LU1983260115.SGD","BK4139","BK7119","BK4521","LU0648005311.SGD","LU0889565916.HKD","CRTO","BK4134","SQNS","BK4082","DAVA","IE00B2B36J28.USD","BCS","SNN","BK4207","BCYC","IE0034235188.USD","BDRX","ARGX","BK4009","BK4107","BUD","AMRN","IE0009355771.USD","AFG","BK4158","IE00BJJMRZ35.SGD","BK4505","LU0084288595.USD","PUK","BK4585","BK4117","TRIB","LU0320765992.SGD","IE00B4R5TH58.HKD","SAN","IE00BJT1NW94.SGD","LU2324357040.USD","BK4588","BUD.AU","IE00BFTCPJ56.SGD","BK4162","BK7142","LU0109394709.USD","IE0002141913.USD","DAVA.AU"],"gpt_icon":0},{"id":"2590510653","title":"European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590510653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590510653?lang=en_us&edition=fundamental","pubTime":"2025-12-12 00:10","pubTimestamp":1765469447,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were on the rise late Thursday morning, increasing 0.82% to 1,663.66 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and biopharmaceutical firm Cellectis , which rose 4.6% and 3.9%, respectively. They were followed by telecommunications company Nokia  and pharmaceutical firm Novo Nordisk , which advanced 3.6% and 2.6% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and medical device maker EDAP TMS , which fell 3.8% and 1.7% respectively. They were followed by oil and gas company Eni  and petroleum refiner Equinor , which were off 0.2% each.From the UK and Ireland, the gainers were led by cruise line operator Carnival  and biopharmaceutical company Akari Therapeutics , which increased 4% and 3.4% respectively. They were followed by communications company WPP  and alcoholic beverage company Diageo , whic","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","BK4107","BK4599","BK4141","BK4142","NCNA","BK4547","EDAP","NOK","AKTX","EQNR","BK4559","IE00BMPRXR70.SGD","BK4532","E","WPP","BK4082","BK4585","BK4117","SNN","BK4020","WPP.AU","AFG","BK4139","IE00BZ1G4Q59.USD","EVAX","LU1093756168.USD","SQNS","BK4007","BK4588","DEO","BK4009","IE00BKVL7J92.USD","NVO.AU","BK4169","CLLS","BDRX","BK4201","BCYC","IE00BMPRXN33.USD","LU1093756325.SGD","DGE.UK","CUK","LU0154236417.USD"],"gpt_icon":1},{"id":"2590539837","title":"European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539837","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590539837?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:08","pubTimestamp":1765382894,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading higher late Wednesday morning, rising 0.67% to 1,636.27 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Cellectis , which climbed 14% and 6.8%, respectively. They were followed by pharmaceutical company Novo Nordisk  and brewing company Anheuser-Busch InBev , which advanced 3.8% and 1.8%, respectively.The decliners from continental Europe were led by biotech firm Evaxion  and semiconductor company Sequans Communications , which fell 3.8% and 2.1%, respectively. They were followed by internet advertising firm Criteo  and medical device maker EDAP TMS , which were down 1.9% each.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and lender HSBC , which rose 33% and 4.1%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics  and educational publish","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMRN","BK4521","BK4009","CRTO","BK4204","IE00BZ1G4Q59.USD","LU0154236417.USD","LU0052756011.USD","BK4141","BK4599","BK4111","EVAX","BK4007","LU0310800965.SGD","BK4107","CLLS","LU2236285917.USD","BK4207","SQNS","PSO","LU1093756168.USD","BK7104","BDRX","BK4588","BUD","LU1093756325.SGD","IE00BKVL7J92.USD","EDAP","BK4117","BK4585","BK4158","NCNA","BK4139","IE00BFMHRM44.USD","NVO","LU0128525689.USD","LU1267930227.SGD","AKTX","TRIB","DBVT","BCYC","BK7119","BK4532","HSBC","00005","BK4082"],"gpt_icon":1},{"id":"2590358352","title":"European Equities Traded in the US as ADRs Little Changed in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590358352","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590358352?lang=en_us&edition=fundamental","pubTime":"2025-12-09 00:01","pubTimestamp":1765209714,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Monday morning, easing less than 0.1% to 1,630.2 on the S&P Europe Select ADR Index.From continental Europe,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756168.USD","EVAX","BK4183","TRIB","BK4599","BK4139","AUTL","BNTX","DBVT","SNY","ULVR.UK","AMRN","MTLS","EDAP","BK4532","BK4592","UL","BK4551","DGE.UK","BHP","BK4559","BK4585","BK7095","BK4588","DEO","IE00BKVL7J92.USD","AKTX","BK4168","IE00BZ1G4Q59.USD","BDRX","BK7507","LU0124676726.USD","BK4169","LU0300736062.USD","LU1093756325.SGD","BK4082","BK4007","BK4535","BK4548","LU0300736492.USD","IE00BFXG1179.USD","BK4568","BK7511","LU0689626769.HKD","LU0154236417.USD","BK4546","BK7104","UN","BK4023","SLN"],"gpt_icon":1},{"id":"2589533237","title":"Evaxion Unveils Promising Preclinical Data for Off-the-Shelf AML Vaccine EVX-04","url":"https://stock-news.laohu8.com/highlight/detail?id=2589533237","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589533237?lang=en_us&edition=fundamental","pubTime":"2025-12-08 19:19","pubTimestamp":1765192752,"startTime":"0","endTime":"0","summary":"Evaxion A/S has announced new preclinical data for its acute myeloid leukemia  vaccine candidate, EVX-04. The results were presented in an oral session at the American Society of Hematology  Annual Meeting and Exposition in Orlando, Florida. The data show that EVX-04, designed with Evaxion's proprietary AI-Immunology platform, induces strong specific T-cell responses and prevents tumor growth in preclinical models. EVX-04 targets multiple non-conventional endogenous retrovirus  tumor antigens and is developed as an off-the-shelf therapeutic cancer vaccine. According to the company, the off-the-shelf vaccine concept behind EVX-04 may also have potential applications in other hard-to-treat cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8chL28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2589821763","title":"Evaxion Unveils Promising Preclinical Data for AML Vaccine EVX-04 at ASH Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589821763","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589821763?lang=en_us&edition=fundamental","pubTime":"2025-12-07 03:00","pubTimestamp":1765047615,"startTime":"0","endTime":"0","summary":"Evaxion A/S, a clinical-stage biotechnology company specializing in AI-powered immunology, has announced new preclinical data for its acute myeloid leukemia  vaccine candidate, EVX-04. The results, which demonstrate that EVX-04 triggers strong specific T-cell responses and effectively prevents tumor growth in preclinical models, were presented at the American Society of Hematology  Annual Meeting and Exposition in Orlando, Florida. EVX-04 is an off-the-shelf therapeutic cancer vaccine developed using Evaxion's proprietary AI-Immunology platform and targets non-conventional endogenous retrovirus  tumor antigens. The company indicates that the off-the-shelf vaccine concept underlying EVX-04 has potential applications across other hard-to-treat cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nNDL5HFgP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","NDAQ","BK4585","BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","LU0314104364.USD","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD","LU2210150020.SGD","SG9999014013.SGD","EVAX"],"gpt_icon":0},{"id":"2586266977","title":"European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586266977","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586266977?lang=en_us&edition=fundamental","pubTime":"2025-11-27 00:03","pubTimestamp":1764172980,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were surging higher late Wednesday morning, rising 1.25% to 1,614.11 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical companies Novo Nordisk  and Ascendis Pharma , which rose 3.5% and 1.8%, respectively. They were followed by biopharmaceutical company DBV Technologies  and lender Banco Santander , which were up 1.7% and 1.6%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and brewing company Anheuser-Busch InBev , which fell 4.6% and 1%, respectively. They were followed by biotech firm Evaxion  and pharmaceutical company Sanofi , which were off 0.9% each.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics  and NuCana , which increased 5.5% and 3.7%, respectively. They were followed by lenders Barclays  and Lloyds Banking Group , which advanced 3.2% each.The decliners from the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","BK7104","BK4107","BK4599","IE00BFXG1179.USD","AUTL","SAN.AU","NCNA","DBVT","AKTX","SAN","BK4559","SNY","BK4532","BK7142","BCS","LYG","ASND","BK4585","BUD","BK4521","BK4117","BK4207","AFG","BK4139","IE00BZ1G4Q59.USD","EVAX","LU0109394709.USD","LU1093756168.USD","BK4007","BK4158","BK4588","DEO","LU0889565916.HKD","BK7119","IE00BKVL7J92.USD","MREO","NVO.AU","BK4169","CLLS","BCYC","LU1093756325.SGD","LU0320765992.SGD","BUD.AU","DGE.UK","BK4505","LU0154236417.USD"],"gpt_icon":1},{"id":"2586562496","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586562496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586562496?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:14","pubTimestamp":1764000859,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week little changed late Monday morning, edging 0.1% higher to 1,572.55 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and internet browser company Opera , which advanced 10% and 2.4%, respectively. They were followed by medical device maker EDAP TMS  and telecommunications company Nokia , which increased 1.7% and 1.5%, respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and internet advertising firm Criteo , which fell 7.8% and 1.4%, respectively. They were followed by oil and gas company Eni , which was down 1%.From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group  and Bicycle Therapeutics , which rose 3.6% each. They were followed by biotech firm Trinity Biotech  and biopharmaceutical company NuCana , which were up 3.2% and 1.7%, respectively","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","TRIB","BK4585","EDAP","BK4082","BK4007","BK7104","BK4505","CLLS","IE00BMPRXN33.USD","BK4599","EVAX","NOK","IE00BMPRXR70.SGD","BK4023","BK4139","BK4107","AFG","NVO","BK4020","BK4532","CRTO","LU1093756168.USD","WPP","BDRX","NCNA","IE00BZ1G4Q59.USD","BK4201","LU1093756325.SGD","BK4009","WPP.AU","LU0154236417.USD","IE00BKVL7J92.USD","BK4588","BK4208","OPRA","BK4117","NGG","E","IE00BFMHRM44.USD","MREO","BK4547","BCYC","AKTX"],"gpt_icon":1},{"id":"2585890142","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down 3% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2585890142","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585890142?lang=en_us&edition=fundamental","pubTime":"2025-11-22 00:01","pubTimestamp":1763740869,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking higher Friday morning, rising 0.65% to 1,561.36 on the S&P Europe Select ADR Index, which is down close to 3% for  the wee","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","ULVR.UK","BK4204","BK4546","IHG","BK7062","AUTL","BK4115","SQNS","BK4158","BK4142","BK7119","EVAX","MTLS","BK4139","BK4117","TEF","BTI.AU","UN","BK4075","LU0124676726.USD","DEO","BK4183","BK4559","BK4592","CLLS","NCNA","UL","BUD","OPRA","BK4023","DGE.UK","BUD.AU","BK4141","BK4169","SLN","BCYC","BK4111","LU0689626769.HKD","BTI","LU2543165471.USD","BK4588","AFG","PSO","BK4585","LU0006061336.USD"],"gpt_icon":0},{"id":"2585814965","title":"BRIEF-Evaxion A/S Prospectus Relates To Offer And Sale By Selling Shareholder000 Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585814965","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585814965?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:30","pubTimestamp":1763735447,"startTime":"0","endTime":"0","summary":"BRIEF-Evaxion A/S Prospectus Relates To Offer And Sale By Selling Shareholder000 Ordinary SharesNov 21  - Evaxion A/S EVAX.O:EVAXION A/S: PROSPECTUS RELATES TO OFFER AND SALE BY SELLING SHAREHOLDER OF UP TO AN AGGREGATE OF 38,450,000 ORDINARY SHARESSource text: [ID:n0001104659-25-114804]Further company coverage: EVAX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WW1M9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2585146533","title":"Evaxion Biotech files to sell 38.45M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2585146533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585146533?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:50","pubTimestamp":1763733016,"startTime":"0","endTime":"0","summary":"08:46 EST Evaxion Biotech (EVAX) files to sell 38.45M ordinary shares for holders Published first on TheFly – the ultimate source for real-time, ma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-files-to-sell-38-45m-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-files-to-sell-38-45m-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2585014575","title":"Evaxion a/S: Prospectus Relates to Offer and Sale by Selling Shareholder of up to an Aggregate of 38,450,000 Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585014575","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585014575?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:46","pubTimestamp":1763732798,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WW1M9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2584137351","title":"Evaxion Reports Positive Data for CMV Vaccine Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2584137351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584137351?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:52","pubTimestamp":1763646737,"startTime":"0","endTime":"0","summary":"Evaxion Biotech ( ($EVAX) ) has shared an announcement. On November 20, 2025, Evaxion A/S announced positive data from its cytomegalovirus (CMV) va...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-reports-positive-data-for-cmv-vaccine-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-reports-positive-data-for-cmv-vaccine-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2584384134","title":"Evaxion Announces Positive Data for Lead Antigens in Cytomegalovirus (Cmv) Vaccine Program Evx-V1","url":"https://stock-news.laohu8.com/highlight/detail?id=2584384134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584384134?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:07","pubTimestamp":1763644075,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW10S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2584313101","title":"Evaxion Unveils Novel AI-Discovered Antigens Showing Protective Effects in CMV Vaccine Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2584313101","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584313101?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:04","pubTimestamp":1763643893,"startTime":"0","endTime":"0","summary":"Evaxion A/S, a clinical-stage TechBio company, has announced positive preclinical data for its novel cytomegalovirus  vaccine program, EVX-V1. Using its proprietary AI-Immunology platform, Evaxion has identified entirely new CMV antigens that have demonstrated the ability to induce specific immune responses, inhibit viral infection, and reduce cell-to-cell spread in both cellular and animal models. The EVX-V1 vaccine candidate combines these AI-discovered antigens with AI-optimized versions of established vaccine targets, including a proprietary pre-fusion glycoprotein B  antigen that has shown superior CMV neutralization compared to traditional gB antigens. Preclinical development is ongoing, with further antigen investigation and optimization underway. The company did not indicate whether these results have already been presented at a scientific meeting or will be presented in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDLsLbwB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2584926065","title":"Evaxion Biotech Q3 Basic EPS USD 0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2584926065","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584926065?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:53","pubTimestamp":1763571219,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Evaxion Biotech Q3 pretax profit USD 4.352 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202512:00:09.673 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD6J2GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2584954562","title":"Evaxion Biotech Increases Share Capital Following Warrant Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2584954562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584954562?lang=en_us&edition=fundamental","pubTime":"2025-11-19 00:27","pubTimestamp":1763483273,"startTime":"0","endTime":"0","summary":"Evaxion Biotech ( ($EVAX) ) has shared an announcement. On November 4, 2025, Evaxion Biotech announced a share capital increase following the exerc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-increases-share-capital-following-warrant-exercise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-increases-share-capital-following-warrant-exercise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2583205592","title":"European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2583205592","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583205592?lang=en_us&edition=fundamental","pubTime":"2025-11-14 00:19","pubTimestamp":1763050780,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly higher late Thursday morning, rising 0.11% to 1,641.58 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications operator Telefonica  and oil and gas company TotalEnergies , which rose 3.9% and 2.1%, respectively. They were followed by biopharmaceutical company Grifols  and semiconductor company Sequans Communications , which gained 1.9% and 1.3% respectively.The decliners from continental Europe were led by biotech companies BioNTech  and Evaxion , which declined 6.1% and 5% respectively. They were followed by accommodations booking company trivago  and internet browser company Opera , which were down 2.8% and 2.5% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Amarin , which advanced 2.4% and 1.3% respectively. They were followed by pharmaceutical company AstraZeneca  and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443465.HKD","AFG","TEF","LU2129689431.USD","BK4505","BNTX","TTE","LU0889565916.HKD","LU2237443622.USD","BK4111","BK4585","LU0320765992.SGD","PSO","TRVG","BK4141","LU2237443382.USD","EVAX","BK4117","BK4588","BK4009","BK4535","LU2237443895.HKD","LU1829250122.USD","MREO","OPRA","SLN","BK4115","LU2417539215.USD","AUTL","BK4568","BK4107","LU2129689514.USD","BDRX","AZN","LU2236285917.USD","SQNS","BK4077","AMRN","LU2237443549.SGD","LU2456880835.USD","LU2129689605.HKD","BK4139","WPP","BK4561","BK4023","GRFS","WPP.AU","BK4201","BK4548","LU0109394709.USD"],"gpt_icon":0},{"id":"2582723063","title":"Evaxion A/S Announces 2026 Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2582723063","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582723063?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:52","pubTimestamp":1762955533,"startTime":"0","endTime":"0","summary":"Evaxion Biotech ( ($EVAX) ) has shared an announcement. On November 12, 2025, Evaxion A/S announced its financial calendar for 2026, detailing key ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-a-s-announces-2026-financial-calendar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-a-s-announces-2026-financial-calendar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2582379233","title":"Evaxion A/S to Report Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379233","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379233?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952447,"startTime":"0","endTime":"0","summary":"Evaxion A/S has announced the following future financial events: - March 5, 2026: Full year 2025 financial results - April 16, 2026: Annual General Meeting - May 7, 2026: First quarter 2026 financial results - August 20, 2026: Second quarter 2026 financial results - November 19, 2026: Third quarter 2026 financial results Results will be released on the company website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evaxion A/S published the original content used to generate this news brief via GlobeNewswire  on November 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL4Zdhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","LU2095319765.USD","EVAX","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","BK4139","IE00B64PRP62.GBP","BK4588","NDAQ","IE00BGHQF748.EUR","LU2210149790.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0801},{"period":"1month","weight":0.1248},{"period":"3month","weight":0.9404},{"period":"6month","weight":1.5259},{"period":"1year","weight":0.2256},{"period":"ytd","weight":0.3863}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.307156},{"month":2,"riseRate":0,"avgChangeRate":-0.092268},{"month":3,"riseRate":0,"avgChangeRate":-0.116351},{"month":4,"riseRate":0.6,"avgChangeRate":0.075553},{"month":5,"riseRate":0.4,"avgChangeRate":0.067918},{"month":6,"riseRate":0.2,"avgChangeRate":-0.044814},{"month":7,"riseRate":0.4,"avgChangeRate":0.060856},{"month":8,"riseRate":0.6,"avgChangeRate":-0.04913},{"month":9,"riseRate":1,"avgChangeRate":0.19717},{"month":10,"riseRate":0.4,"avgChangeRate":0.102065},{"month":11,"riseRate":0.2,"avgChangeRate":-0.236379},{"month":12,"riseRate":0,"avgChangeRate":-0.176489}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction